# A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia

Study · id `cardio:ct-nct06622772` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06622772](<https://clinicaltrials.gov/study/NCT06622772>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06622772

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

## Technical summary

Registry record NCT06622772. Randomized; no masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2023-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 212 participants (enrolled count; ClinicalTrials.gov record NCT06622772, source copy `cardio:ctgov-nct06622772-2024-10-02`, retrieved 2026-10-26)
- Started: 2022-03-01 (actual) (ClinicalTrials.gov record NCT06622772, source copy `cardio:ctgov-nct06622772-2024-10-02`, retrieved 2026-10-26)
- Primary completion: 2023-04-30 (actual) (ClinicalTrials.gov record NCT06622772, source copy `cardio:ctgov-nct06622772-2024-10-02`, retrieved 2026-10-26)
- Completion: 2024-05-30 (actual) (ClinicalTrials.gov record NCT06622772, source copy `cardio:ctgov-nct06622772-2024-10-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06622772, source copy `cardio:ctgov-nct06622772-2024-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06622772-2024-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia
- Condition: Supraventricular Tachycardia (SVT)
- Intervention (Device): Valsalva assist device
- Intervention (Other): standard Valsalva manoeuvre
- Lead sponsor: Beijing Anzhen Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Device-Assisted vs Standard Valsalva Maneuver for Terminating Supraventricular Tachycardia: A Randomized Clinical Trial (`cardio:pubmed-41670992`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 83969dc14dc43b475574d723294bf953667f64a0c55be01f2284467090af61ed
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
